A61K 38/4833
Thrombin
Official title: {Thrombin (3.4.21.5)}
A61K38/4833 (Thrombin) appears on 398 US grants and 668 published applications in this corpus.
Search patents in A61K- Granted patents
- 398
- Published applications
- 668
- Assignees
- 275
- Inventors
- 899
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 3 |
| 2002 | 3 | 10 |
| 2003 | 5 | 12 |
| 2004 | 2 | 14 |
| 2005 | 11 | 35 |
| 2006 | 9 | 23 |
| 2007 | 11 | 19 |
| 2008 | 10 | 28 |
| 2009 | 8 | 26 |
| 2010 | 6 | 41 |
| 2011 | 12 | 33 |
| 2012 | 25 | 36 |
| 2013 | 27 | 42 |
| 2014 | 30 | 38 |
| 2015 | 31 | 40 |
| 2016 | 23 | 45 |
| 2017 | 24 | 34 |
| 2018 | 21 | 27 |
| 2019 | 17 | 28 |
| 2020 | 16 | 27 |
| 2021 | 14 | 20 |
| 2022 | 14 | 23 |
| 2023 | 9 | 15 |
| 2024 | 14 | 24 |
| 2025 | 14 | 9 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for kidney treatment using omentum, a medical kit for kidney treatment, including the same, and film for kidney treatment, including cured product thereof21 Jul 2026US 12,685,752 B2Rokit Healthcare Inc.
- Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo5 May 2026US 12,616,720 B2RegenLab USA LLC
- Compositions and methods for treating bone injury10 Feb 2026US 12,544,404 B2Board of Regents, The University of Texas System
- Systems, devices and methods for dispensing biocompatible reactive formulations and controlling cross-linking of the reactive components of the biocompatible reactive formulations3 Feb 2026US 12,539,374 B2Ethicon, Inc.
- Process, tube and device for the preparation of wound healant composition27 Jan 2026US 12,533,398 B2RegenLab USA LLC
- Powder composition comprising a haemostatic agent24 Sep 2026US 2026/0284157 A1Centre National De La Recherche Scientifique
- Fitusiran for the treatment of hemophilia a and b in pediatric patients20 Aug 2026US 2026/0240891 A1Genzyme Corporation
- Combination therapies with an anti-factor xi/factor xia antibody13 Aug 2026US 2026/0232796 A1Anthos Therapeutics, Inc.
- Method for producing gel-like wound healing agent, gel-like wound healing agent, and autologous platelet-rich plasma gel preparation kit for wound healing23 Jul 2026US 2026/0207664 A1Rohto Pharmaceutical Co., Ltd.
- Freeze-dried plasma (fdp) for well-balanced coagulation and fibrinolysis, method of preparation and use thereof9 Jul 2026US 2026/0191903 A1Army Medical University, People's Liberation Army, Prc
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Medical implants and fibrosis-inducing agents330US 7,166,570 B2Angiotech International AG · 2007
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Fibrinogen-containing dry preparation, manufacture and use thereof225US 4,442,655 ASerapharm Michael Stroetmann · 1984